|
Video: What is a Stock Split?
|
|
Frequency Therapeutics is a clinical-stage biotechnology company focused on developing therapeutics to activate a person's innate regenerative potential to restore function. Co. develops FX-322 to treat an underlying cause of sensorineural hearing loss, which is the loss of hair cells. Co.'s proprietary approach, Progenitor Cell Activation, uses small molecules to activate progenitor cells within the body to create functional tissue. These progenitor cells, which are closely related to stem cells, are already resident in the targeted location in the body and programmed to develop and differentiate into specific cell types within an organ. According to our FREQ stock split history records, FREQ has had 0 splits. | |
|
FREQ (FREQ) has 0 splits in our FREQ stock split history database.
Looking at the FREQ stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into FREQ shares, starting with a $10,000 purchase of FREQ, presented on a split-history-adjusted basis factoring in the complete FREQ stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/04/2019 |
|
End date: |
11/03/2023 |
|
Start price/share: |
$13.49 |
|
End price/share: |
$0.30 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.78% |
|
Average Annual Total Return: |
-60.61% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$222.42 |
|
Years: |
4.08 |
|
|
|
|
|